28.06.2007 19:00:00

Fresenius Medical Care Announces Ernestine M. Lowrie Award for Clinical Leadership

Fresenius Medical Care North America, operators of the nation’s leading network of dialysis clinics, are pleased to honor Loretta Anderson RN BSN As the inaugural winner of the Ernestine M. Lowrie Award for Clinical Excellence. Mrs. Lowrie was a pioneer in the treatment of kidney failure who began her career as a hemodialysis nurse and became the Chief Operating Officer of the Dialysis Services Division of National Medical Care, a predecessor of Fresenius Medical Care. Known to be uncompromising with respect to the quality of patient care since the earliest days of outpatient dialysis treatment, Mrs. Lowrie is widely credited with developing the policies and procedures that are the foundation for modern dialysis nursing practice. In this way, she had a profound effect on the lives of thousands. This award is presented in her name, to honor her, and as an ongoing tribute to her legacy and long lasting contributions to excellence in nephrology nursing. Ms. Anderson was presented the award in the presence of more than 2,200 attendees to the recent Fresenius Medical Services Clinical Managers national conference. After graduating Nursing School in 1980, Ms. Anderson began her career at Queens Artificial Kidney Center, Queens, NY. Recognized early for her care and concern for the quality of life of her patients, she was quickly promoted to Charge Nurse, and subsequently was the natural choice for Clinical Manager when the incumbent retired. Her focus is on a team approach to care, and the team she leads has won Platinum level awards as a Center of Excellence for five successive years, since the inception of this distinction. Her team truly demonstrates the dedication and focus on quality of care that epitomize clinical excellence. Ms. Anderson was recognized, as were six other finalist nominees from across the country, each in their own way, leaders in nephrology nursing, following in the footsteps of the precedent for excellence set by Mrs. Lowrie. The other nominee Clinical Managers included: Tamyn Needham from North Carolina, Sharleen Wilson from Louisiana, Marcy Umbricht from Illinois, Minerva Mulero from Puerto Rico, Laura Kute from Texas and Debbie Arrington from Arizona. Fresenius Medical Care is proud to honor all of the nominees, and of their contribution to providing UltraCareR to every patient, every treatment. About Fresenius Medical Care North America Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest, integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,500,000 individuals worldwide. Through its network of approximately 2,194 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to approximately 169,216 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS-p). For more information about Fresenius Medical Care's U.S. network of more than 1,500 dialysis facilities, visit the Company's website at www.ultracare-dialysis.com. For more information about Fresenius Medical Care, visit the Company’s websites: www.fmcna.com or www.fmc-ag.com.

Analysen zu Fresenius Medical Care (FMC) (ADRS)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Fresenius Medical Care (FMC) (ADRS) 20,60 1,98% Fresenius Medical Care (FMC) (ADRS)